Successful private placement and retail offering - Zelluna ASA raises NOK 58 million to advance the world’s first 'off-the-shelf” TCR-NK therapy, ZI-MA4-1, into Phase I clinical trials and develop the ...

Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other ...

Newly decoded brain circuits make memories more stable as part of learning, according to a study led by NYU Langone Health ...

Stroke remains one of the most serious health emergencies that can strike anywhere, anytime and to anyone. When blood flow to ...

The U.S. Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

As Halloween approaches, stories of witches and their potions resurface, often featuring eerie plants like belladonna, mandrake and mugwort. These ...

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

Plant a seed and, if the conditions are right, the seed grows. The process seems simple enough at first glance and is something many of us may feel like we learned in elementary school.

In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It ...

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

Investigators from Mass General Brigham have developed a way to promote antitumor immunity by hijacking cellular machinery within cancer cells. The study demonstrated that inducing cancer cells to ...

A UBC chemist developing advanced materials transforming how we diagnose disease and reduce waste has been awarded an Arthur ...